Class IITerminatedD-1271-2019
Drug recall · May 8, 2019
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth S recall
Why: Defective Delivery System: difficult to express
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019
- Lots / codes
Lot: 190212AB BUD: 5/13/2019
- Quantity
- 249 syringes
- Company
- Pacifico National, Inc. dba AmEx Pharmacy, Melbourne, FL
- Distribution
- Nationwide in the US
- Initiated
- April 19, 2019 · Voluntary: Firm initiated
- Classified
- May 7, 2019
- Reported
- May 8, 2019
- Ended
- February 16, 2021
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.